Ratings by Chardan
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 9/3/2026 | Keay Nakae | Vyome Holdings | HIND | New Coverage | Buy (N/A) |
3.50 (N/A) |
2.18 (2.22) |
1.83% | Details |
| 9/1/2026 | Keay Nakae | Rocket Pharmaceuticals | RCKT | New Coverage | Buy (N/A) |
11.00 (N/A) |
3.72 (3.86) |
3.76% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 988 more... | |||||||||
